SCOPUS 정보 검색 플랫폼

Volumn 50, Issue 6, 2009, Pages 1459-1461

Premarket assessment of devices for treatment of critical limb ischemia: The role of Objective Performance Criteria and Goals

(3) Geraghty, Patrick J a Matsumura, Jon S b Conte, Michael S c

a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE (United States)

b UNIVERSITY OF WISCONSIN MADISON (United States)

c UNIVERSITY OF CALIFORNIA (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPLASTY; ARTICLE; DEVICE; FOOD AND DRUG ADMINISTRATION; HEART ASSIST DEVICE; LIMB ISCHEMIA; MARKET; MARKETING; METHODOLOGY; POPULATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SAMPLE SIZE; VALIDITY;

ADVISORY COMMITTEES; CATHETERIZATION, PERIPHERAL; CONTROLLED CLINICAL TRIALS AS TOPIC; CRITICAL ILLNESS; DEVICE APPROVAL; EQUIPMENT DESIGN; EQUIPMENT SAFETY; EVIDENCE-BASED MEDICINE; EXTREMITIES; HUMANS; ISCHEMIA; PRACTICE GUIDELINES AS TOPIC; PRODUCT SURVEILLANCE, POSTMARKETING; RESEARCH DESIGN; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VASCULAR SURGICAL PROCEDURES;

EID: 70649097211 PISSN: 07415214 EISSN: None Source Type: Journal
DOI: 10.1016/j.jvs.2009.10.041 Document Type: Article

Times cited : (19)

References (4)

1
- 84878988379
- Accessed June 15, 2009
- The Least Burdensome Provisions of the FDA Modernization Act of 1997: Concept and Principles; Final Guidance for FDA and Industry. http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm085994.htm Accessed June 15, 2009
- The Least Burdensome Provisions of the FDA Modernization Act of 1997: Concept and Principles; Final Guidance for FDA and Industry

2
- 33747349203
- FDA perspective on clinical trial design for cardiovascular devices
- Chen E., Sapirstein W., Ahn C., Swain J., and Zuckerman B. FDA perspective on clinical trial design for cardiovascular devices. Ann Thorac Surg 82 (2006) 773-775
- (2006) Ann Thorac Surg , vol.82 , pp. 773-775
- Chen, E.¹ Sapirstein, W.² Ahn, C.³ Swain, J.⁴ Zuckerman, B.⁵

3
- 33747362048
- Prosthetic heart valves: Objective Performance Criteria versus randomized clinical trial
- Grunkemeier G.L., Jin R., and Starr A. Prosthetic heart valves: Objective Performance Criteria versus randomized clinical trial. Ann Thorac Surg 82 (2006) 776-780
- (2006) Ann Thorac Surg , vol.82 , pp. 776-780
- Grunkemeier, G.L.¹ Jin, R.² Starr, A.³

4
- 34249903911
- FDA perspective on clinical trial design for femoropopliteal stent correction of peripheral vascular insufficiency cardiovascular devices
- Goode J., Sapirstein W., and Zuckerman B. FDA perspective on clinical trial design for femoropopliteal stent correction of peripheral vascular insufficiency cardiovascular devices. Catheter Cardiovasc Interv 69 (2007) 920-921
- (2007) Catheter Cardiovasc Interv , vol.69 , pp. 920-921
- Goode, J.¹ Sapirstein, W.² Zuckerman, B.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.